(Q49097736)

18 February 2018

title

Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation. (English)

1 reference

18 February 2018

0 references

1 reference

Arai Y

1

1 reference

18 February 2018

Yamazaki M

2

1 reference

18 February 2018

Mori O

3

1 reference

18 February 2018

Muramatsu H

4

1 reference

18 February 2018

Asano G

5

1 reference

18 February 2018

Katayama Y

6

1 reference

18 February 2018

language of work or name

English

0 references

publication date

1 January 2001

1 reference

18 February 2018

published in

Brain Research

1 reference

18 February 2018

volume

888

1 reference

18 February 2018

page(s)

287-296

1 reference

18 February 2018

issue

2

1 reference

18 February 2018

Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Neuropathological stageing of Alzheimer-related changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: Light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Epitope mapping of LB509, a monoclonal antibody directed against human alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Identification of two distinct synucleins from human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Diffuse Lewy body disease in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Alpha-synuclein in Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

Alpha-synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex of Guam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903082-1

10.1016/S0006-8993(00)03082-1

7 January 2021

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

11150486

1 reference

18 February 2018